RegentAtlantic Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $11.9M | Buy |
137,803
+1,552
| +1% | +$139K | 0.36% | 42 |
|
|
2022
Q2 | $12.4M | Buy |
136,251
+3,222
| +2% | +$286K | 0.41% | 42 |
|
|
2022
Q1 | $10.9M | Buy |
133,029
+708
| +0.5% | +$55.8K | 0.31% | 57 |
|
|
2021
Q4 | $10.1M | Buy |
132,321
+5,343
| +4% | +$426K | 0.28% | 62 |
|
|
2021
Q3 | $9.54M | Buy |
126,978
+10,253
| +9% | +$780K | 0.29% | 63 |
|
|
2021
Q2 | $9.08M | Buy |
116,725
+4,453
| +4% | +$331K | 0.28% | 62 |
|
|
2021
Q1 | $8.26M | Sell |
112,272
-900
| -0.8% | -$66.4K | 0.28% | 68 |
|
|
2020
Q4 | $8.83M | Buy |
113,172
+17,976
| +19% | +$1.37M | 0.35% | 54 |
|
|
2020
Q3 | $7.54M | Buy |
95,196
+1,833
| +2% | +$144K | 0.34% | 63 |
|
|
2020
Q2 | $6.89M | Buy |
93,363
+14,483
| +18% | +$1.09M | 0.38% | 60 |
|
|
2020
Q1 | $5.79M | Sell |
78,880
-20,616
| -21% | -$1.62M | 0.45% | 57 |
|
|
2019
Q4 | $8.63M | Sell |
99,496
-1,105
| -1% | -$90.8K | 0.52% | 44 |
|
|
2019
Q3 | $8.08M | Sell |
100,601
-3,189
| -3% | -$256K | 0.53% | 47 |
|
|
2019
Q2 | $8.3M | Buy |
103,790
+3,488
| +3% | +$267K | 0.56% | 44 |
|
|
2019
Q1 | $7.96M | Buy |
100,302
+975
| +1% | +$72.9K | 0.55% | 44 |
|
|
2018
Q4 | $7.24M | Buy |
99,327
+24,113
| +32% | +$1.7M | 0.61% | 40 |
|
|
2018
Q3 | $5.09M | Buy |
75,214
+1,642
| +2% | +$105K | 0.39% | 73 |
|
|
2018
Q2 | $4.26M | Sell |
73,572
-1,277
| -2% | -$72K | 0.37% | 74 |
|
|
2018
Q1 | $3.89M | Sell |
74,849
-7,568
| -9% | -$409K | 0.32% | 90 |
|
|
2017
Q4 | $4.42M | Sell |
82,417
-7,827
| -9% | -$434K | 0.36% | 73 |
|
|
2017
Q3 | $5.51M | Buy |
90,244
+5,975
| +7% | +$362K | 0.48% | 57 |
|
|
2017
Q2 | $5.15M | Sell |
84,269
-6,478
| -7% | -$394K | 0.47% | 60 |
|
|
2017
Q1 | $5.5M | Sell |
90,747
-6,830
| -7% | -$414K | 0.51% | 54 |
|
|
2016
Q4 | $5.48M | Sell |
97,577
-21,994
| -18% | -$1.29M | 0.53% | 53 |
|
|
2016
Q3 | $7.12M | Sell |
119,571
-5,735
| -5% | -$335K | 0.74% | 40 |
|
|
2016
Q2 | $6.89M | Sell |
125,306
-8,159
| -6% | -$434K | 0.66% | 38 |
|
|
2016
Q1 | $6.74M | Sell |
133,465
-17,580
| -12% | -$861K | 0.74% | 36 |
|
|
2015
Q4 | $7.61M | Buy |
151,045
+15,507
| +11% | +$782K | 0.81% | 38 |
|
|
2015
Q3 | $6.39M | Buy |
135,538
+11,740
| +9% | +$624K | 0.61% | 42 |
|
|
2015
Q2 | $6.72M | Buy |
123,798
+33,500
| +37% | +$1.88M | 0.6% | 41 |
|
|
2015
Q1 | $4.95M | Buy |
90,298
+8,045
| +10% | +$456K | 0.43% | 61 |
|
|
2014
Q4 | $4.46M | Sell |
82,253
-1,780
| -2% | -$99.2K | 0.38% | 68 |
|
|
2014
Q3 | $4.75M | Sell |
84,033
-1,686
| -2% | -$94.7K | 0.44% | 58 |
|
|
2014
Q2 | $4.73M | Sell |
85,719
-630
| -0.7% | -$34.4K | 0.44% | 60 |
|
|
2014
Q1 | $4.68M | Sell |
86,349
-7,165
| -8% | -$371K | 0.46% | 58 |
|
|
2013
Q4 | $4.47M | Sell |
93,514
-841
| -0.9% | -$38.4K | 0.43% | 62 |
|
|
2013
Q3 | $4.29M | Sell |
94,355
-7,029
| -7% | -$321K | 0.47% | 56 |
|
|
2013
Q2 | $4.49M | Buy |
+101,384
| New | +$4.53M | 0.53% | 47 |
|
Other funds holding MRK
RegentAtlantic Capital's MRK Position: Q3 2022 in Review
RegentAtlantic Capital increased its Merck (MRK) stake by 1.1% in Q3 2022, buying an estimated $139K and bringing the position to 137,803 shares worth $11.9M. The position accounts for 0.36% of the portfolio, ranked #42.
RegentAtlantic Capital first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $12.4M in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- RegentAtlantic Capital held 137,803 shares of Merck worth $11.9M as of Q3 2022.
- RegentAtlantic Capital bought 1,552 Merck shares in Q3 2022, an estimated $139K.
- Merck made up 0.36% of RegentAtlantic Capital's portfolio in Q3 2022, its #42 holding.
- RegentAtlantic Capital first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Merck position peaked at $12.4M in Q2 2022.
- 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.